The Drug Enforcement Agency has extended the flexibilities that allow physicians to prescribe controlled substances via telemedicine without an in-person evaluation until November.
Six senators, led by Sen. Edward Markey, D-Mass., have urged the Drug Enforcement Agency to permanently extend flexibilities that allow physicians to prescribe controlled substances via telemedicine without an in-person evaluation.
New York City-based NYC Health + Hospitals was the lone health system winner in the 2023 MedTech Breakthrough Awards honoring the top health technology platforms.
Telehealth company Amwell has reported $389.5 million in losses, with an impairment charge contributing to the majority of that total, according to the company’s first-quarter earnings posted May 3.
The Drug Enforcement Agency is looking to temporarily extend the flexibility of prescribing controlled substances via telemedicine beyond the COVID-19 public health emergency, The Washington Post reported May 3.